Cite
HARVARD Citation
Pavord, I. et al. (n.d.). P44 Dupilumab reduces exacerbations and improves lung function in uncontrolled, moderate-to-severe asthma patients regardless of prior exacerbation history in the phase 3 LIBERTY ASTHMA QUEST study. Thorax. pp. A121-A122. [Online].